Shah, M., Gallipoli, P., Lyons, J., Holyoake, T. L. and Jorgensen, H. (2012) Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro. Blood Cells, Molecules, and Diseases, 48(3), pp. 199-201. (doi: 10.1016/j.bcmd.2012.01.005)
![[img]](https://eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
64199.pdf 294kB |
Publisher's URL: http://dx.doi.org/10.1016/j.bcmd.2012.01.005
| Item Type: | Articles (Letter) |
|---|---|
| Additional Information: | NOTICE: this is the author’s version of a work that was accepted for publication in Blood, Cells, Molecules and Diseases. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Blood, Cells, Molecules and Diseases, [48, 3, (2012)] doi:10.1016/j.bcmd.2012.01.005. |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Holyoake, Professor Tessa and Gallipoli, Dr Paolo and Jorgensen, Dr Heather |
| Authors: | Shah, M., Gallipoli, P., Lyons, J., Holyoake, T. L., and Jorgensen, H. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
| Journal Name: | Blood Cells, Molecules, and Diseases |
| Publisher: | Academic Press |
| ISSN: | 1079-9796 |
| ISSN (Online): | 1096-0961 |
| Copyright Holders: | Copyright © 2012 Elsevier |
| First Published: | First published in Blood, Cells, Molecules and Diseases 48(3):199-201 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
| Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information